🇺🇸 FDA
Patent

US 10239912

Modulators of 5′-nucleotidase, ecto and the use thereof

granted A61KA61K31/70A61K31/7052

Quick answer

US patent 10239912 (Modulators of 5′-nucleotidase, ecto and the use thereof) held by Arcus Biosciences, Inc. expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
47
CPC classes
A61K, A61K31/70, A61K31/7052, A61K31/706, A61K31/7064